7:55 AM · 20 July 2023

Economic calendar: CBRT decision and Q2 earnings reports!

USD/TRY
Forex
-
-
  • Quarterly earnings of: Johnson&Johnson, Abbott Laboratories, Philip Morris, American Airlines

  • Jobless claims report and CBRT decision in focus

Today's macroeconomic calendar will be filled with readings of quarterly results. However, this does not mean that we will not get to know some important economic readings. In Poland, attention will focus today on data on wages, employment and industrial production.  Moreover, we are awaiting the CBRT's decision on interest rates, as well as data on unemployment benefits and secondary market home sales from the USA. The calendar for today will be topped off with the Philly FED regional report and natural gas inventory data. 

Quarterly company results:

In Europe, EasyJet, among others, has already presented its results. In the semiconductor market, TSMC's results have caught investors' attention. In the US, these will include Johnson&Johnson, Abbott Laboratories, Philip Morris, BlackStone, Capital One and American Airlines.

Source: XTB

Detailed calendar of the day:

13:00 - Turkey, interest rate decision:

  • Expected 20%; Previously 15%

14:30 - USA, Philly FED index:

  • Expected: -10.1; Previously -13.7

14:30 - US, jobless claims:

  • Expected: 243k; Previously: 237k.

16:00 - US, secondary market home sales

  • Expected: 4.22 million. Previously: 4.3 million

16:30 - USA, natural gas inventories data

  • Expected: 47 bn. Previously: 49 bn.

6 October 2025, 7:14 PM

Daily summary: US100 surges almost 1% 📈Crypto and precious metals on the rise

6 October 2025, 3:06 PM

Stock of the Month: Will Meta win the AI ​​race?

6 October 2025, 1:03 PM

AMD rises on the wave of the OpenAI deal. Pre-market trading shows a 25% increase in shares.

6 October 2025, 12:00 PM

DE40: France pulls the market lower 📉

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits